Showing 1 - 20 results of 49 for search 'A.  A.  Tryakin', query time: 1.53s Refine Results
  1. 1
    The role of regorafenib in the treatment of metastatic colorectal cancer

    The role of regorafenib in the treatment of metastatic colorectal cancer by A A Tryakin

    Published 2016-06-01
    Get full text
    Article
  2. 2
    Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen'

    Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen' by A A Tryakin

    Published 2009-09-01
    Get full text
    Article
  3. 3
    Vektibiks (panitumumab) – novoe monoklonal'noe antitelok retseptoram epidermal'nogo faktora rosta pri lechenii metastaticheskogo kolorektal'nogo raka

    Vektibiks (panitumumab) – novoe monoklonal'noe antitelok retseptoram epidermal'nogo faktora rosta pri lechenii metastaticheskogo kolorektal'nogo raka by A A Tryakin, S A Tyulyandin

    Published 2009-12-01
    Get full text
    Article
  4. 4
    Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer

    Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer by A. A. Tryakin, P. A. Balunov

    Published 2018-11-01
    Get full text
    Article
  5. 5
    Neoadjuvant chemotherapy for colon cancer

    Neoadjuvant chemotherapy for colon cancer by M. Yu. Fedyanin, A. A. Tryakin

    Published 2022-06-01
    Get full text
    Article
  6. 6
    Neoadjuvant therapy for locally advanced rectal cancer

    Neoadjuvant therapy for locally advanced rectal cancer by M. Yu. Fedyanin, A. A. Tryakin

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Regorafenib: from clinical research to clinical practice

    Regorafenib: from clinical research to clinical practice by M Yu Fedyanin, A A Tryakin

    Published 2017-09-01
    Get full text
    Article
  8. 8
    BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY

    BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-02-01
    Get full text
    Article
  9. 9
    Khimioterapiya bol'nykhrasprostranennym rakom tolstoy kishki

    Khimioterapiya bol'nykhrasprostranennym rakom tolstoy kishki by M Yu Fedyanin, A A Tryakin, S A Tyulyandin

    Published 2010-06-01
    Get full text
    Article
  10. 10
    Localization of the primary tumor of the colon: аre there essential differences?

    Localization of the primary tumor of the colon: аre there essential differences? by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2017-12-01
    Get full text
    Article
  11. 11
    Role of microsatellite instability in colon cancer

    Role of microsatellite instability in colon cancer by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-02-01
    Get full text
    Article
  12. 12
    CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY

    CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-05-01
    Get full text
    Article
  13. 13
    PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION

    PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-02-01
    Get full text
    Article
  14. 14
    FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

    FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-02-01
    Get full text
    Article
  15. 15
    Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

    Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2018-07-01
    Get full text
    Article
  16. 16
    Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer?

    Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer? by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tyulyandin

    Published 2015-10-01
    Get full text
    Article
  17. 17
    ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY

    ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2015-02-01
    Get full text
    Article
  18. 18
    Colorectal cancer, screening: achievements и opportunities

    Colorectal cancer, screening: achievements и opportunities by E. A. Polyanskaya, M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin

    Published 2018-12-01
    Get full text
    Article
  19. 19
    Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer

    Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer by M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. A. Tyulyandin

    Published 2017-04-01
    Get full text
    Article
  20. 20
    CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES

    CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES by N. V. Dobrova, O. O. Gordeeva, E. V. Chernoglazova, A. A. Tryakin

    Published 2017-11-01
    Get full text
    Article

Search Tools: